Datavault AI Licenses Smart Contracts IP to Wellgistics Health for PharmacyChain and EinsteinRx Platforms
TL;DR
Datavault AI's smart contract licensing gives Wellgistics Health a competitive edge by reducing PBM costs and enhancing transparency across 6,500+ pharmacies.
Datavault AI's smart contracts integrate with PharmacyChain and EinsteinRx platforms using Web 3.0 technology to automate prescription tracking and pharmaceutical distribution.
This partnership modernizes pharmaceutical distribution by improving prescription transparency and reducing healthcare costs, creating a more efficient system for patients and providers.
Datavault AI's Web 3.0 smart contracts now power prescription tracking across 6,500+ pharmacies through Wellgistics' PharmacyChain and EinsteinRx platforms.
Found this article helpful?
Share it with your network and spread the knowledge!
Datavault AI Inc. (NASDAQ: DVLT) has exclusively licensed its proprietary smart contracts intellectual property to Wellgistics Health (NASDAQ: WGRX) for integration into the PharmacyChain and EinsteinRx platforms. This strategic partnership will enable Web 3.0 smart contract functions across a network of more than 6,500 pharmacies, representing a significant advancement in pharmaceutical distribution technology.
The integration supports Wellgistics' comprehensive plan to streamline prescription tracking, reduce pharmacy benefit manager (PBM)-driven costs, enhance transparency for payers, and modernize U.S. pharmaceutical distribution through data automation and artificial intelligence integration. This collaboration marks a substantial step forward in applying blockchain and smart contract technology to healthcare operations, potentially transforming how prescription medications are tracked and managed throughout the supply chain.
Datavault AI's technology platform provides comprehensive solutions with a collaborative focus through its Acoustic Science and Data Science Divisions. The company's Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation, and secure monetization. The Information Data Exchange enables Digital Twins and licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity.
The company's cloud-based platform serves multiple industries, including healthcare, through HPC software licensing and offers AI and Machine Learning automation, third-party integration, detailed analytics and data, marketing automation, and advertising monitoring. The technology suite is completely customizable, allowing for tailored solutions across various sectors. Additional information about Datavault AI is available in the company's newsroom at https://ibn.fm/DVLT.
This licensing agreement represents a significant development in healthcare technology infrastructure, potentially setting new standards for efficiency and transparency in pharmaceutical distribution. The integration of smart contracts into pharmacy operations could fundamentally change how prescriptions are processed, tracked, and managed, reducing administrative burdens and improving accuracy throughout the medication distribution process. The partnership between these two NASDAQ-listed companies demonstrates the growing importance of blockchain and AI technologies in modernizing traditional healthcare systems and addressing longstanding challenges in pharmaceutical supply chain management.
Curated from InvestorBrandNetwork (IBN)
